Efficacy of regulatory T-cell immunotherapy: Are inflammatory cytokines key determinants? [1]

Nature Reviews Immunology

Volumn 8, Issue 1, 2008, Pages

  Bayry, Jagadeesh ^a   Lacroix Desmazes, Sébastien ^a   Dasgupta, Suryasarathi ^a   Kazatchkine, Michel D ^a   Kaveri, Srini V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CYTOKINE; INTERLEUKIN 10; L SELECTIN; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADOPTIVE TRANSFER; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DENDRITIC CELL; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MACROPHAGE ACTIVATION; MONOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE; UPREGULATION; ADOPTIVE IMMUNOTHERAPY; IMMUNOLOGY; METHODOLOGY; NOTE; TRANSPLANTATION;

AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; INFLAMMATION; T-LYMPHOCYTES, REGULATORY;

EID: 37549067013     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2138-c1     Document Type: Letter

References (15)

1. Roncarolo, M.-G. & Battaglia, M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nature Rev. Immunol. 7, 585-598 (2007).
2. Leipe, J., Skapenko, A., Lipsky, P. E. & Schulze-Koops, H. Regulatory T cells in rheumatoid arthritis. Arthritis Res. Ther. 7, 93-99 (2005).
3. high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J. Immunol. 176, 5293-5298 (2006).
4. + regulatory T cells. J. Immunol. 178, 4184-4193 (2007).
5. Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-α therapy. J. Exp. Med. 200, 277-285 (2004).
6. hi T-regulatory cells. Blood 108, 253-261 (2006).
7. + regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum. 56, 732-742 (2007).
8. + regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy. Drug Discov. Today 12, 548-552 (2007).
9. + T cells. Arthritis Res. Ther. 7, R291-R301 (2005).
10. + immunoregulatory T cells may not be involved in controlling autoimmune arthritis. Arthritis Res. Ther. 5, R106-R113 (2003).
11. Nadkarni, S., Mauri, C. & Ehrenstein, M. R. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med. 204, 33-39 (2007).
12. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971-979 (2004).
13. + T-cells from patients with type 1 diabetes. Diabetes 54, 92-99 (2005).
14. Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M. D. & Kaveri, S. V. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nature Clin. Pract. Rheumatol. 3, 262-272 (2007).
15. Buch, M. H., Marzo-Ortega, H., Bingham, S. J. & Emery, P. Long-term treatment of rheumatoid arthritis with tumour necrosis factor α blockade: outcome of ceasing and restarting biologicals. Rheumatology (Oxford) 43, 243-244 (2004).